Inventor · disambiguated record
Darren Mckerrecher
Also filed as: MCKERRECHER DARREN
19 granted patents·19 pending applications·243 citations·filing 2000–2011
95Inventor score
Files withASTRAZENECA AB20JOHNSTONE CRAIG6BERGER MARKUS3CAULKETT PETER WILLIAM RODNEY3MCKERRECHER DARREN2
Top patents by PatentIndex Score
38 records- 0196US7524957B2Compounds effecting glucokinaseASTRAZENECA AB·Filed 2008·Granted Apr 28, 2009·31 cites·22 claims
- 0294US7745475B2Heteroaryl benzamide derivatives as GLK activatorsASTRAZENECA AB·Filed 2005·Granted Jun 29, 2010·14 cites·3 claims
- 0393US7642259B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2006·Granted Jan 5, 2010·18 cites·3 claims
- 0492US8492560B2Quinazoline derivatives as angiogenesis inhibitorsSTOKES ELAINE S E·Filed 2011·Granted Jul 23, 2013·28 cites·4 claims
- 0592US7642263B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2008·Granted Jan 5, 2010·16 cites·3 claims
- 0690US7842694B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2008·Granted Nov 30, 2010·11 cites·3 claims
- 0790US7390908B2Compounds effecting glucokinaseASTRAZENECA AB·Filed 2002·Granted Jun 24, 2008·33 cites·19 claims
- 0890US7074800B1Quinazoline derivatives as angiogenesis inhibitorsASTRAZENECA AB·Filed 2000·Granted Jul 11, 2006·37 cites·26 claims
- 0988US7728030B2Chemical compounds 572ASTRAZENECA AB·Filed 2007·Granted Jun 1, 2010·9 cites·4 claims
- 1088US7671060B2Heteroaryl benzamide derivativesASTRAZENECA AB·Filed 2007·Granted Mar 2, 2010·13 cites·3 claims
- 1183US8030340B2Indazolyl sulphonamide derivatives useful as glucocorticoid modulatorsASTRAZENECA AB·Filed 2007·Granted Oct 4, 2011·8 cites·12 claims
- 1282US8143290B2Chemical compounds 572BERGER MARKUS·Filed 2010·Granted Mar 27, 2012·5 cites·12 claims
- 1379US6806274B1Quinazoline derivativesASTRAZENECA UK LTD·Filed 2000·Granted Oct 19, 2004·15 cites·7 claims
- 1473US7951830B2Compounds effecting glucokinaseASTRAZENECA AB·Filed 2009·Granted May 31, 2011·1 cites·11 claims
- 1568US7709505B2Benzofuran derivatives, process for their preparation and intermediates thereofASTRAZENECA AB·Filed 2003·Granted May 4, 2010·4 cites·8 claims
- 1666US2010197644A1Chemical Compounds 572BERGER MARKUS·Filed 2009·Application pending·0 cites
- 1765US7977328B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2008·Granted Jul 12, 2011·0 cites·12 claims
- 1864US7964725B2Heteroarylbenzamide derivatives for use in the treatment of diabetesASTRAZENECA AB·Filed 2009·Granted Jun 21, 2011·0 cites·1 claims
- 1959US2009253676A1Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of DiabetesASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2057US2007112040A1Amino nicotinate derivatives as glucokinase (GLK) modulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2155US2006004017A1Quinazoline derivatives as angiogenesis inhibitorsASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2249US2008280872A1Benzamide Derivatives and Their Use as Glucokinase Activating AgentsJOHNSTONE CRAIG·Filed 2005·Application pending·0 cites
- 2348US2009062351A1Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (glk) activatorsCAULKETT PETER WILLIAM RODNEY·Filed 2004·Application pending·0 cites
- 2447US2011053910A12 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetesMCKERRECHER DARREN·Filed 2006·Application pending·0 cites
- 2546US2007255062A1Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) ActivatorsJOHNSTONE CRAIG·Filed 2004·Application pending·0 cites
- 2645US7943607B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2006·Granted May 17, 2011·0 cites·17 claims
- 2745US2004214868A1Amino nicotinate derivatives as glucokinase (GLK) modulatorsFiled 2002·Application pending·0 cites
- 2845US2008280874A1Phenoxy Benzamide Compounds with Utility in the Treatment of Type 2 Diabetes and ObesityJOHNSTONE CRAIG·Filed 2005·Application pending·0 cites
- 2945US2009018157A1Chemical compoundsJOHNSTONE CRAIG·Filed 2004·Application pending·0 cites
- 3044US2008234273A1Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of DiabetesMCKERRECHER DARREN·Filed 2006·Application pending·0 cites
- 3144US2010160286A1Heteroarylcarbamoylbenzene derivatives for the treatment of diabetesASTRAZENECA UK LTD AB·Filed 2006·Application pending·0 cites
- 3244US2011059941A12-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulatorsCAULKETT PETER WILLIAM RODNEY·Filed 2006·Application pending·0 cites
- 3343US2011034432A1Benzamide derivatives and their use as glucokinase activating agentsASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 3442US2009105263A1Heterobicyclic compounds as glucokinase activatorsCAULKETT PETER WILLIAM RODNEY·Filed 2006·Application pending·0 cites
- 3541US2007287693A1Benzamide Derivatives That Act Upon The Glucokinase EnzymeJOHNSTONE CRAIG·Filed 2005·Application pending·0 cites
- 3641US2008312207A1CompoundsJOHNSTONE CRAIG·Filed 2005·Application pending·0 cites
- 3739US7498335B2Method of producing an antiangiogenic or vascular permeability reducing effectASTRAZENECA AB·Filed 2001·Granted Mar 3, 2009·0 cites·4 claims
- 3837US2012065173A1Chemical compoundsBERGER MARKUS·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →